Skip to main content
. 2016 May 27;7(34):55732–55740. doi: 10.18632/oncotarget.9675

Table 1. RCT studies selecting conversion resection after conversion therapy.

Study Num Regimens ORR R0 R Jadad
RAISE[15] 536 FOLFIRI+Ramu 13.4 ---- 6
536 FOLFIRI 12.5
Ranhua 2015 [16] 65 FOLFIRI+Beva 47.7 ---- 7
77 FOLFIRI 28.6 7
Marc 2010 [17] 303 FOLFIRI+Pani 40.0 ---- 5
294 FOLFIRI 9.9
Eric 2012 [18] 611 FOLFIRI+Afli 19.8 ---- 5
605 FOLFIRI 11.1
Le-Chi 2013 [19] 70 mFOLFOX6+Cetu 57.1 25.7 4
68 mFOLFOX6 29.4 7.4
Eric 2009 [20] 599 FOLFIRI+Cetu 46.9 5.1 7
599 FOLFIRI 38.7 2.0
Yuguo 2015 [21] 65 FOLFIRI+Pani+beva 46.2 ---- 5
77 FOLFIRI 26.0
Carsten 2009 [22] 113 FOLFOX4+Cetu 32.7 16.0 6
120 FOLFOX4 22.5 4.3
MAC CION [23] 362 CAP/FOLFOX/+Cetu 40.9 15.0 5
367 CAP/FOLFOX 32.4 13.0
PRIME [24] 326 FOLFOX4+Pani 54.9 8.3 6
331 FOLFOX4 48.0 7.0
FIRE-3 [25] 297 FOLFIRI+Cetu 62.0 ---- 7
295 FOLFIRI+Beva 58.0
PEAK [26] 139 mFOLFOX6+Pani 59.0 ---- 7
139 mFOLFOX6+Beva 54.7
CALGB/SWOG 80405 [27] 270 FOLFIRI/OX+Cetu 68.9 5
256 FOLFIRI/OX+Beva 55.9